FDA Drug Recalls

Recalls / Class II

Class IID-0637-2025

Product

Chlorpromazine Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141. NDC: 16714-050-01

Brand name
Chlorpromazine Hydrochloride
Generic name
Chlorpromazine Hydrochloride
Active ingredient
Chlorpromazine Hydrochloride
Route
Oral
NDCs
16714-047, 16714-048, 16714-049, 16714-050, 16714-051
FDA application
ANDA213368
Affected lot / code info
Lot #: Z305456, Exp Date 31-10-25; Z401156, Exp Date 28-02-26; Z407306, Exp Date 30-11-26

Why it was recalled

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Recalling firm

Firm
Zydus Pharmaceuticals (USA) Inc
Manufacturer
Northstar Rx LLC
Notification channel
N/A
Type
Voluntary: Firm initiated
Address
73 Route 31 N, N/A, Pennington, New Jersey 08534-3601

Distribution

Quantity
N/A
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2025-09-03
FDA classified
2025-09-10
Posted by FDA
2025-09-17
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0637-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Chlorpromazine Hydrochloride · FDA Drug Recalls